A. Brüttin and H. Brüssow, Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy, Antimicrobial Agents and Chemotherapy, vol.49, issue.7, 2005.
DOI : 10.1128/AAC.49.7.2874-2878.2005

H. Brüssow, What is needed for phage therapy to become a reality in Western medicine? Virology http, pp.42-682200456, 2012.

N. Chanishvili, A Literature Review of the Practical Application of Bacteriophage Research. Eliava Institute of Bacteriophage, Microbiology & Virology, p.184, 2009.

N. Chanishvili, Phage Therapy???History from Twort and d'Herelle Through Soviet Experience to Current Approaches, Adv. Virus Res, vol.83, pp.3-40, 2012.
DOI : 10.1016/B978-0-12-394438-2.00001-3

A. M. Comeau, F. Tétart, S. N. Trojet, M. Prère, and H. M. Krisch, Phage-Antibiotic Synergy (PAS): ??-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth, PLoS ONE, vol.50, issue.8, p.799, 2007.
DOI : 10.1371/journal.pone.0000799.g005
URL : https://hal.archives-ouvertes.fr/hal-00180524

A. Górski, R. Miedzybrodzki, J. Borysowski, B. Weber-dabrowska, M. Lobocka et al., Bacteriophage therapy for the treatment of infections, Curr. Opin. Investig. Drugs, vol.10, pp.766-774, 2009.

A. Górski, R. Mie-?dzybrodzki, J. Borysowski, K. Da-?browska, P. Wierzbicki et al., Phage as a Modulator of Immune Responses, Virus Res, vol.83, pp.41-71
DOI : 10.1016/B978-0-12-394438-2.00002-5

A. R. Hall, D. De-vos, V. P. Friman, J. P. Pirnay, and A. Buckling, 1. Effects of sequential and simultaneous application of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in waxmoth larvae, 2012.
URL : https://hal.archives-ouvertes.fr/in2p3-00148681

, Appl. Environ. Microbiol.. (Epub ahead of print

P. Http,

P. H. , Phage for Human Application Group Europe

J. P. Pirnay, D. De-vos, G. Verbeken, M. Merabishvili, N. Chanishvili et al., The Phage Therapy Paradigm: Pr??t-??-Porter or Sur-mesure?, Pharmaceutical Research, vol.2, issue.4, pp.934-937, 2011.
DOI : 10.1038/nrmicro822

J. P. Pirnay, G. Verbeken, T. Rose, S. Jennes, M. Zizi et al., Introducing yesterday???s phage therapy in today???s medicine, Future Virology, vol.71, issue.4, pp.379-390, 2012.
DOI : 10.1016/j.virusres.2006.01.010

H. W. Smith and M. B. Huggins, Successful Treatment of Experimental Escherichia coli Infections in Mice Using Phage: its General Superiority over Antibiotics, Microbiology, vol.128, issue.2, pp.307-318, 1982.
DOI : 10.1099/00221287-128-2-307

G. Verbeken, D. De-vos, M. Vaneechoutte, M. Merabishvili, M. Zizi et al., European regulatory conundrum of phage therapy, Future Microbiology, vol.69, issue.5, pp.485-491, 2007.
DOI : 10.1128/AAC.49.7.2874-2878.2005

B. Weber-dabrowska, M. Mulczyk, and A. Górski, Bacteriophage Therapy of Bacterial Infections: An Update of our Institute???s Experience, Arch. Immunol. Ther. Exp, vol.48, pp.547-551, 2000.
DOI : 10.1007/978-94-015-9702-9_15

A. Wright, C. H. Hawkins, E. E. Anggård, and D. R. Harper, ; a preliminary report of efficacy, Clinical Otolaryngology, vol.8, issue.4, pp.349-357, 2009.
DOI : 10.3201/eid0809.020063

, Institut Pasteur